Bladder Cancer:
Altor Bioscience (Immunity Bio) Protocol: QUILT-3.032
- a study for patients with BCG unresponsive high-grade non-muscle invasive bladder cancer
https://clinicaltrials.gov/ct2/show/NCT04142359
Altor Bioscience (Immunity Bio) Protocol: QUILT-2.005
- a study for patients with high-grade non-muscle invasive bladder cancer who have never received BCG treatment
https://clinicaltrials.gov/ct2/show/NCT02138734
Prostate Cancer:
Bayer HealthCare Pharmaceuticals, Inc. Protocol: 20609
- a study to compare the effects of treatment between two medications on physical function and daily activity in men with castration-resistant prostate cancer
https://clinicaltrials.gov/ct2/show/NCT04157088
Myriad Genetic Laboratories, Inc. Protocol: URO-008
- a long-term data collection registry study to evaluate treatment decisions and clinical outcomes in men age 65 and older with favorable intermediate-risk prostate cancer
Enteric Hyperoxaluria:
Allena Pharmaceuticals Protocol: ALLN-177-302
- kidney stone study to evaluate a medication to reduce oxalate excretion in patients with a history of bariatric surgery, Crohn’s disease, short bowel or other malabsorption syndromes
https://clinicaltrials.gov/ct2/show/NCT03847090
Overactive Bladder in Men:
Urovant Sciences Protocol: URO-901-3005
- a study for males age 45 and older with overactive bladder symptoms currently on medication therapy for enlarged prostate
https://clinicaltrials.gov/ct2/show/study/NCT03902080
Stress Urinary Incontinence in Women:
Solace Therapeutics, Inc Protocol: Vesair Trial (VAPOR)
- a study to evaluate a bladder control system for treating SUI in post-menopausal women
https://clinicaltrials.gov/ct2/show/NCT04026347
BPH (Benign Prostatic Hyperplasia):
Urotronic, Inc Protocol: PINNACLE
- study to establish the safety and efficacy of the Optilume™ BPH Catheter System in treating BPH in males ages 50-80 years old
https://clinicaltrials.gov/ct2/show/NCT04131907
Uncomplicated UTI (Urinary Tract Infection):
GlaxoSmithKline Protocol: 212390
- a study comparing Gepotidacin to Nitrofurantoin for the treatment of uncomplicated UTIs in females >12 years of age
https://clinicaltrials.gov/ct2/show/NCT04187144
Hypogonadism in Men:
Allergan, Inc Protocol: Androderm
- a study to determine 24 hour blood pressure at 16 weeks of treatment with Androderm patch
https://clinicaltrials.gov/ct2/show/NCT04320745
Repeat Prostate Biopsy:
Exosome Diagnostics, Inc Protocol: ECT2018-0001A
- evaluation of ExoDx prostate test to correlate results with the outcome of prostate biopsies in men with a prior negative biopsy